Madhulina Maity
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Madhulina Maity has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Anindita Banerjee
Indian Council of Medical Research-National Institute of Cholera and Enteric Diseases Kolkata India
1 shared publication - Anirban Roy
Virology Laboratory, DAC Regional Research Institute, Kolkata, India
1 shared publication - Avipsha Sarkar
Institute of Engineering and Management, Newtown Sector (School of University of Engineering and Management, Kolkata, India
1 shared publication - Bijita Bhowmick
Institute of Life Sciences, Department of Biotechnology, Govt. of India, Bhubaneswar, India
1 shared publication - Debadatta Nayak
CCRH, New Delhi, India
1 shared publication - Mamta Chawla-Sarkar
Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata 700010, India
1 shared publication
Latest Publications
- 20 December 2025
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (2) , 932-955
Eupatorium perfoliatum Counteracts TNF-α Mediated Pathogenesis in Chikungunya Virus Infection
Chikungunya virus (CHIKV) infection, a neglected tropical disease causes severe morbid symptoms that can be persistent and debilitating. CHIKV mediated pathogenesis is a complex combination of host and viral factors that results in immune responses causing incapacitating symptoms. A significant player of disease development is tumor necrosis factor-α (TNF-α), the villain responsible for unremitting inflammation and disease pathogenesis. This study explored the potential of TNF-α dysregulation that can enhance CHIKV mediated disease development along with the prospective of ultradiluted hydroethanolic preparation of Eupatorium perfoliatum to limit the symptoms. In silico molecular docking studies revealed that Eupatorium perfoliatum has strong molecular interactions with TNF-α. To substantiate the results, in vivo transcriptional and translational quantification of TNF-α by qRT-PCR and immunohistochemistry before and after treatment with candidate medicine was performed which produced similar outcome. Macroscopic and histology results also revealed neuropathogenesis and muscle waste caused by CHIKV infection and a systemic lowering of the same after treatment. Hub genes of TNF-α were analyzed to identify the other probable players that can augment CHIKV mediated pathogenesis. qRT-PCR results showed that the candidate medicine could lower the transcriptional overexpression of the hub genes thereby lowering disease pathogenesis. In vitro cytopathic effects upon infection were also lowered by the candidate medicine. Therefore, this study helps not only to recognize the possible villainous role of TNF-α but to also identify novel therapeutic markers of CHIKV mediated disease development by hub gene analysis and the potential of the alternative medicine, ultradiluted Eupatorium perfoliatum in lowering the same. Graphical Abstract
- 20 December 2025
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (2) , 932-955
Eupatorium perfoliatum Counteracts TNF-α Mediated Pathogenesis in Chikungunya Virus Infection
Chikungunya virus (CHIKV) infection, a neglected tropical disease causes severe morbid symptoms that can be persistent and debilitating. CHIKV mediated pathogenesis is a complex combination of host and viral factors that results in immune responses causing incapacitating symptoms. A significant player of disease development is tumor necrosis factor-α (TNF-α), the villain responsible for unremitting inflammation and disease pathogenesis. This study explored the potential of TNF-α dysregulation that can enhance CHIKV mediated disease development along with the prospective of ultradiluted hydroethanolic preparation of Eupatorium perfoliatum to limit the symptoms. In silico molecular docking studies revealed that Eupatorium perfoliatum has strong molecular interactions with TNF-α. To substantiate the results, in vivo transcriptional and translational quantification of TNF-α by qRT-PCR and immunohistochemistry before and after treatment with candidate medicine was performed which produced similar outcome. Macroscopic and histology results also revealed neuropathogenesis and muscle waste caused by CHIKV infection and a systemic lowering of the same after treatment. Hub genes of TNF-α were analyzed to identify the other probable players that can augment CHIKV mediated pathogenesis. qRT-PCR results showed that the candidate medicine could lower the transcriptional overexpression of the hub genes thereby lowering disease pathogenesis. In vitro cytopathic effects upon infection were also lowered by the candidate medicine. Therefore, this study helps not only to recognize the possible villainous role of TNF-α but to also identify novel therapeutic markers of CHIKV mediated disease development by hub gene analysis and the potential of the alternative medicine, ultradiluted Eupatorium perfoliatum in lowering the same. Graphical Abstract
- Open Access
Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: An endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations
Accumulation of mutations within the genome is the primary driving force for viral evolution within an endemic setting. This inherent feature often leads to altered virulence, infectivity and transmissibility as well as antigenic shift to escape host immunity, which might compromise the efficacy of vaccines and antiviral drugs. Therefore, we aimed at genome-wide analyses of circulating SARS-CoV-2 viruses for the emergence of novel co-existing mutations and trace their spatial distribution within India. Comprehensive analysis of whole genome sequences of 441 Indian SARS-CoV-2 strains revealed the occurrence of 33 different mutations, 21 being distinctive to India. Emergence of novel mutations were observed in S glycoprotein (7/33), NSP3 (6/33), RdRp/NSP12 (4/33), NSP2 (2/33) and N (2/33). Non-synonymous mutations were found to be 3.4 times more prevalent than synonymous mutations. We classified the Indian isolates into 22 groups based on the co-existing mutations. Phylogenetic analyses revealed that representative strain of each group divided themselves into various sub-clades within their respective clades, based on the presence of unique co-existing mutations. India was dominated by A2a clade (55.60%) followed by A3 (37.38%) and B (7%), but exhibited heterogeneous distribution among various geographical regions. The A2a clade mostly predominated in East India, Western India and Central India, whereas A3 clade prevailed in South and North India. In conclusion, this study highlights the divergent evolution of SARS-CoV-2 strains and co-circulation of multiple clades in India. Monitoring of the emerging mutations would pave ways for vaccine formulation and designing of antiviral drugs.
Open AccessComprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: An endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations
Accumulation of mutations within the genome is the primary driving force for viral evolution within an endemic setting. This inherent feature often leads to altered virulence, infectivity and transmissibility as well as antigenic shift to escape host immunity, which might compromise the efficacy of vaccines and antiviral drugs. Therefore, we aimed at genome-wide analyses of circulating SARS-CoV-2 viruses for the emergence of novel co-existing mutations and trace their spatial distribution within India. Comprehensive analysis of whole genome sequences of 441 Indian SARS-CoV-2 strains revealed the occurrence of 33 different mutations, 21 being distinctive to India. Emergence of novel mutations were observed in S glycoprotein (7/33), NSP3 (6/33), RdRp/NSP12 (4/33), NSP2 (2/33) and N (2/33). Non-synonymous mutations were found to be 3.4 times more prevalent than synonymous mutations. We classified the Indian isolates into 22 groups based on the co-existing mutations. Phylogenetic analyses revealed that representative strain of each group divided themselves into various sub-clades within their respective clades, based on the presence of unique co-existing mutations. India was dominated by A2a clade (55.60%) followed by A3 (37.38%) and B (7%), but exhibited heterogeneous distribution among various geographical regions. The A2a clade mostly predominated in East India, Western India and Central India, whereas A3 clade prevailed in South and North India. In conclusion, this study highlights the divergent evolution of SARS-CoV-2 strains and co-circulation of multiple clades in India. Monitoring of the emerging mutations would pave ways for vaccine formulation and designing of antiviral drugs.